Developing and evaluating live CME sessions for family physicians on cancer and heredity: An RCT.
- Conditions
- genetics, general practice, general practitioners (GPs), cancer, continuing educational meetings (CME), simulation patients, randomized controlled trial (RCT).
- Registration Number
- NL-OMON27614
- Lead Sponsor
- The author is based at VU University Medical Center and Maastricht University MUMC+.
- Brief Summary
Houwink, E. J., L. Henneman, et al. (2012). "Prioritization of future genetics education for general practitioners: a Delphi study." Genetics in medicine : official journal of the American College of Medical Genetics. Genet Med advance online publication 5 January 2012. <br><br> Houwink, E. J., S. J. van Luijk, et al. (2011). "Genetic educational needs and the role of genetics in primary care: a focus group study with multiple perspectives." BMC family practice 12: 5.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 66
To be eligible for the study, Dutch GPs are required to work full- or part-time in a family practice setting. GPs are not required to comfortless use the internet, however a computer with internet access is necessary to access the online and login accessible genetic CME questionnaires.
GPs are excluded if they are unwilling or unable to participate in either randomly assigned study group.
GPs outside the provinces of Noord Holland and Limburg in the Netherlands. The live genetic CME sessions are only held in these provinces and because we wish to not have selection bias and high validity of our testresults.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Knowledge on skills of genetics (such as how to refer and to whom) is assessed immediately before the intervention, one month after the intervention and 3 months later by mail linked to an online questionnaire. <br><br /><br /><br>Skills and attitude is assessed through non anonymous live simulation patient contact in general practice shortly before the intervention, one month after the intervention and 3 months later. The participants in the control groups are visited by the simulation patients at the same time, they participated in the live genetic CME after all the live visits by the simulation patients and questionnaires are done. The non anonymous simulationpatients were instructed to tell the GPs once in the practice room they are there for the project, it is therefore semi anonymous because of logistic reasons.
- Secondary Outcome Measures
Name Time Method Participants are also one month after the intervention. 3 months later the intervention group is further assessed for applicability of the acquired knowledge in daily genetic patient care.